Patents by Inventor Adam Skepner

Adam Skepner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulators of hepatic lipoprotein metabolism
    Patent number: 9526720
    Abstract: The present invention relates to compounds that are useful for modulating hepatic cholesterol metabolism in an animal. The invention includes methods of making and using the compounds of the invention. The invention further provides methods of treating, preventing and/or alleviating a cholesterol related disorder, a cardiovascular disease and/or liver disease in an animal, such as a human, comprising administering compounds of the invention, or pharmaceutically acceptable salts or solvates thereof, to the animal.
    Type: Grant
    Filed: August 19, 2013
    Date of Patent: December 27, 2016
    Assignee: The Broad Institute, Inc.
    Inventors: Marek Maria Nagiec, Jose R. Perez, Michelle Palmer, Adam Skepner, Eamon Comer
  • Modulators of Hepatic Lipoprotein Metabolism
    Publication number: 20150216855
    Abstract: The present invention relates to compounds that are useful for modulating hepatic cholesterol metabolism in an animal. The invention includes methods of making and using the compounds of the invention. The invention further provides methods of treating, preventing and/or alleviating a cholesterol related disorder, a cardiovascular disease and/or liver disease in an animal, such as a human, comprising administering compounds of the invention, or pharmaceutically acceptable salts or solvates thereof, to the animal.
    Type: Application
    Filed: August 19, 2013
    Publication date: August 6, 2015
    Inventors: Marek Maria Nagiec, Jose R. Perez, Michelle Palmer, Adam Skepner, Eamon Comer
  • Transfection of cartilage and matrices thereof in vitro
    Publication number: 20050124038
    Abstract: The invention provides methods for transfecting and/or transducing neocartilage or juvenile cartilage comprising infecting cultured neocartilage or juvenile cartilage with a recombinant vector. Preferably, the vector is adenovirus fiber type 51. Transfected and/or transduced chondrocyte cells and intact neocartilage or juvenile cartilage are also provided.
    Type: Application
    Filed: July 14, 2004
    Publication date: June 9, 2005
    Inventors: Dean Aguiar, Adam Skepner, H. Adkisson